Literature DB >> 15126366

Characterization of the interaction of ingenol 3-angelate with protein kinase C.

Noemi Kedei1, Daniel J Lundberg, Attila Toth, Peter Welburn, Susan H Garfield, Peter M Blumberg.   

Abstract

Ingenol 3-angelate (I3A) is one of the active ingredients in Euphorbia peplus, which has been used in traditional medicine. Here, we report the initial characterization of I3A as a protein kinase C (PKC) ligand. I3A bound to PKC-alpha in the presence of phosphatidylserine with high affinity; however, under these assay conditions, little PKC isoform selectivity was observed. PKC isoforms did show different sensitivity and selectivity for down-regulation by I3A and phorbol 12-myristate 13-acetate (PMA) in WEHI-231, HOP-92, and Colo-205 cells. In all of the three cell types, I3A inhibited cell proliferation with somewhat lower potency than did PMA. In intact CHO-K1 cells, I3A was able to translocate different green fluorescent protein-tagged PKC isoforms, visualized by confocal microscopy, with equal or higher potency than PMA. PKC-delta in particular showed a different pattern of translocation in response to I3A and PMA. I3A induced a higher level of secretion of the inflammatory cytokine interleukin 6 compared with PMA in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction. I3A was unable to cause the same extent of association of the C1b domain of PKC-delta with lipids, compared with PMA or the physiological regulator diacylglycerol, and was able to partially block the association induced by these agents, measured by surface plasmon resonance. The in vitro kinase activity of PKC-alpha induced by I3A was lower than that induced by PMA. The novel pattern of behavior of I3A makes it of great interest for further evaluation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126366     DOI: 10.1158/0008-5472.can-03-3403

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Drug discovery from natural sources.

Authors:  Young-Won Chin; Marcy J Balunas; Hee Byung Chai; A Douglas Kinghorn
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

Review 2.  Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Med Oncol       Date:  2013-10-31       Impact factor: 3.064

3.  Injury-induced HDAC5 nuclear export is essential for axon regeneration.

Authors:  Yongcheol Cho; Roman Sloutsky; Kristen M Naegle; Valeria Cavalli
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

Review 4.  Enzymatic chemistry of cyclopropane, epoxide, and aziridine biosynthesis.

Authors:  Christopher J Thibodeaux; Wei-chen Chang; Hung-wen Liu
Journal:  Chem Rev       Date:  2011-10-21       Impact factor: 60.622

5.  Evaluation of the skin sensitization, photoirritation, and photoallergic potential of ingenol mebutate gel in healthy volunteers.

Authors:  Jonathan S Dosik; Maureen Damstra; Carol Udell; Peter Welburn
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

6.  Charge density influences C1 domain ligand affinity and membrane interactions.

Authors:  Jessica S Kelsey; Tamas Geczy; Nancy E Lewin; Noemi Kedei; Colin S Hill; Julia S Selezneva; Christopher J Valle; Wonhee Woo; Inna Gorshkova; Peter M Blumberg
Journal:  Chembiochem       Date:  2014-04-28       Impact factor: 3.164

7.  Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines.

Authors:  Viviane A O Silva; Marcela N Rosa; Olga Martinho; Amilcar Tanuri; João Paulo Lima; Luiz F Pianowski; Rui M Reis
Journal:  Invest New Drugs       Date:  2019-02-01       Impact factor: 3.850

8.  13-Oxyingenol dodecanoate, a cytotoxic ingenol derivative, induces mitochondrial apoptosis and caspase-dependent Akt decrease in K562 cells.

Authors:  Ming Liu; Weiyi Zhang; Genzhu Wang; Xiaoping Song; Xingzeng Zhao; Xiangyun Wang; Xin Qi; Jing Li
Journal:  Tumour Biol       Date:  2015-11-28

9.  Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta.

Authors:  Wing-Yiu Lee; Peter Hampson; Lydia Coulthard; Farrah Ali; Mike Salmon; Janet M Lord; Dagmar Scheel-Toellner
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

10.  Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells.

Authors:  K A Benhadji; M Serova; A Ghoul; E Cvitkovic; C Le Tourneau; S M Ogbourne; F Lokiec; F Calvo; P Hammel; S Faivre; E Raymond
Journal:  Br J Cancer       Date:  2008-12-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.